Suppr超能文献

儿科透析和肾移植患者的体重过轻、超重和肥胖。

Underweight, overweight and obesity in paediatric dialysis and renal transplant patients.

机构信息

ESPN/ERA-EDTA Registry, Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

出版信息

Nephrol Dial Transplant. 2013 Nov;28 Suppl 4:iv195-iv204. doi: 10.1093/ndt/gft259. Epub 2013 Aug 23.

Abstract

BACKGROUND

The prevalence of childhood overweight is rising worldwide, but in children on renal replacement therapy (RRT) a poor nutritional status is still the primary concern. We aimed to study the prevalence of, and factors associated with, underweight and overweight/obesity in the European paediatric RRT population. Moreover, we assessed the evolution of body mass index (BMI) after the start of RRT.

METHODS

We included 4474 patients younger than 16 years from 25 countries of whom BMI data, obtained between 1995 and 2010, were available within the European Society for Paediatric Nephrology/European Renal Association-European Dialysis and Transplant Association Registry. Prevalence estimates for under- and overweight/obesity were calculated using age and sex-specific criteria of the World Health Organization (WHO, 0-1 year olds) and the International Obesity Task Force cut-offs (2-15 year olds).

RESULTS

The prevalence of underweight was 3.5%, whereas 20.8% of the patients were overweight and 12.5% obese. Factors associated with being underweight were receiving dialysis treatment and infant age. Among transplanted recipients, a very short stature (OR: 1.64, 95% CI: 1.40-1.92) and glucocorticoid treatment (OR: 1.23, 95% CI: 1.03-1.47) were associated with a higher risk of being overweight/obese. BMI increased post-transplant, and a lower BMI and a higher age at the start of RRT were associated with greater BMI changes during RRT treatment.

CONCLUSIONS

Overweight and obesity, rather than underweight, are highly prevalent in European children on RRT. Short stature among graft recipients had a strong association with overweight, while underweight appears to be only a problem in infants. Our findings suggest that nutritional management in children receiving RRT should focus as much on the prevention and treatment of overweight as on preventing malnutrition.

摘要

背景

儿童超重的发病率在全球范围内呈上升趋势,但在接受肾脏替代治疗(RRT)的儿童中,营养状况不佳仍是首要问题。我们旨在研究欧洲儿科 RRT 人群中体重不足和超重/肥胖的患病率及其相关因素。此外,我们评估了 RRT 开始后体重指数(BMI)的变化。

方法

我们纳入了来自 25 个国家的 4474 名年龄小于 16 岁的患者,其中 25 个国家的 BMI 数据在 1995 年至 2010 年间获得,并在欧洲儿科学会/欧洲肾脏协会-欧洲透析与移植协会注册处可用。使用世界卫生组织(WHO,0-1 岁)和国际肥胖工作组(IOTF)切点(2-15 岁)的年龄和性别特异性标准计算体重不足和超重/肥胖的患病率估计值。

结果

体重不足的患病率为 3.5%,而超重的患者占 20.8%,肥胖的患者占 12.5%。接受透析治疗和婴儿年龄与体重不足有关。在接受移植的患者中,矮小身材(OR:1.64,95%CI:1.40-1.92)和糖皮质激素治疗(OR:1.23,95%CI:1.03-1.47)与超重/肥胖的风险增加相关。移植后 BMI 增加,RRT 开始时 BMI 较低和年龄较大与 RRT 治疗期间 BMI 变化较大相关。

结论

在接受 RRT 的欧洲儿童中,超重和肥胖比体重不足更为常见。移植物受者的矮小身材与超重有很强的关联,而体重不足似乎只是婴儿的问题。我们的研究结果表明,接受 RRT 的儿童的营养管理应同样关注超重的预防和治疗,以及防止营养不良。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验